Growth Metrics

Fulgent Genetics (FLGT) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to -$6.8 million.

  • Fulgent Genetics' Income towards Parent Company rose 5366.14% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.2 million, marking a year-over-year increase of 7248.56%. This contributed to the annual value of -$43.8 million for FY2024, which is 7324.35% up from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Income towards Parent Company is -$6.8 million, which was up 5366.14% from -$19.2 million recorded in Q2 2025.
  • Fulgent Genetics' Income towards Parent Company's 5-year high stood at $200.7 million during Q1 2021, with a 5-year trough of -$122.9 million in Q4 2023.
  • For the 5-year period, Fulgent Genetics' Income towards Parent Company averaged around $21.0 million, with its median value being -$9.1 million (2024).
  • As far as peak fluctuations go, Fulgent Genetics' Income towards Parent Company surged by 1185694.2% in 2021, and later crashed by 110268.06% in 2023.
  • Fulgent Genetics' Income towards Parent Company (Quarter) stood at $103.7 million in 2021, then crashed by 123.22% to -$24.1 million in 2022, then plummeted by 410.33% to -$122.9 million in 2023, then skyrocketed by 94.95% to -$6.2 million in 2024, then dropped by 9.66% to -$6.8 million in 2025.
  • Its Income towards Parent Company stands at -$6.8 million for Q3 2025, versus -$19.2 million for Q2 2025 and -$11.9 million for Q1 2025.